[英文調查報告書] 美國人工裝植器具、矯正器具、美容整形產品市場

REPORT HIGHLIGHTS

The U.S. market for prosthetics, orthotics and cosmetic enhancement products is expected to increase from $6.8 billion in 2005 to $10.8 billion in 2010, at an AAGR (average annual growth rate) of 9.9%.

Cosmetic enhancement products have a much higher projected AAGR (28.2%) than either prosthetics (5.5%) or orthotics (3.6%). As a result, cosmetic enhancement products will increase their market share to 30.3% in 2010.

Both prostheses and orthoses are expected to lose market share, i.e., from 78.9% to 63.3% and from 8.8% to 6.4%, respectively.

Currently, the largest-selling products are dental crowns and bridges and hip and knee implants. Products expected to show the greatest growth by 2010 include botulinum toxin dermal fillers and dental implants.

U.S. Market for Prosthetics, Orthotics and Cosmetic Enhancement Products, 2004-2010
($ Millions)

U.S. Market for Prosthetics, Orthotics and Cosmetic Enhancement
Products

Source: BCC, Inc

INTRODUCTION

The prosthetics, orthotics and cosmetic enhancement products industries are entering into a period of extraordinary opportunities. This is due to a convergence of technological, demographic, cultural and economic factors. Advances in materials technology, miniaturization, electronics and operative procedures are opening up many new possibilities.

At the same time, the populations of the U.S. and other advanced countries are growing older, resulting in a continual growth in the number of people suffering from physical disabilities and other conditions that medical science increasingly is equipped to ameliorate. Many of these same individuals have enjoyed unprecedented earnings during their working lives, and look forward to financially comfortable retirement years. As a result, they will have the money to spend on prosthetics, orthotics and cosmetic enhancement products, with or without the help of health insurance.

This BCC report is both a survey of products on the marketplace and a preview of things to come. The study examines market opportunities for prosthetic and orthotics devices and cosmetic enhancement products and the technologies that make possible the more advanced products that rapidly are coming into being.

SCOPE OF STUDY

The report contains:

Discussion of major product types and applications, both commercial and developmental
An overview of market size and segmentation, including historical data on sales by application and product type
Market drivers and constraints
Detailed market projections through 2010
Analysis of industry structure, competition and market shares
Discussion of factors that may influence the long-term market for prosthetic and orthotics devices and cosmetic enhancement products.

METHODOLOGY AND INFORMATION SOURCES

The findings and conclusions of this report are based on information gathered from manufacturers and distributors, hospitals, doctors, and other end users. Interview data were combined with information gathered through an extensive review of secondary sources such as trade publications, trade associations, company literature, and on-line databases to produce the baseline market estimates contained in this report.

The base year for analysis and projection is 2004. With 2004 as a baseline, market projections were developed for 2005 to 2010. These projections are based on consensus among the primary contacts in combination with our understanding of the key market drivers and their impact from a historical and analytical perspective. The analytical methodologies used to generate the market estimates are described in detail in the section on Detailed Market Projections.

TABLE OF CONTENTS

INTRODUCTION

STUDY BACKGROUND
STUDY GOALS AND OBJECTIVES
INTENDED AUDIENCE
SCOPE AND FORMAT
METHODOLOGY AND INFORMATION SOURCES
ANALYST CREDENTIALS
RELATED BCC, INC. RESEARCH
BCC ONLINE SERVICES
DISCLAIMER

EXECUTIVE SUMMARY

Summary Table:
U.S. MARKET FOR PROSTHETICS, ORTHOTICS AND COSMETIC ENHANCEMENT PRODUCTS, THROUGH 2010 ($ MILLIONS)
Summary Figure:
U.S. MARKET FOR PROSTHETICS, ORTHOTICS AND COSMETIC ENHANCEMENT PRODUCTS, 2004-2010 ($ MILLIONS)

OVERVIEW OF PROSTHETICS, ORTHOTICS, AND BODY ENHANCEMENT PRODUCTS

GENERAL DESCRIPTION
- PROSTHETICS
- ORTHOTICS
- COSMETIC ENHANCEMENT PRODUCTS
HISTORY
- PROSTHETIC LIMBS
  - Prosthetic Limbs (Continued)
- IMPLANTABLE PROSTHETIC DEVICES
  - Neurostimulators
  - Cardiac Prosthetic Devices
  - Ear Implants
  - Eye Implants
- COSMETIC ENHANCEMENT PRODUCTS
TECHNOLOGIES
- MATERIALS
  - Nanotechnology
    - Synthetic Bone and Tooth Enamel
  - Nanostructured Titanium
- MINIATURIZATION
- ELECTRONICS
  - Microprocessors
  - Motors and Controllers
  - Sensors
  - Power Sources
- OPERATIVE PROCEDURES
  - Computer-Assisted Hip and Knee Replacement Surgery
  - Robotic Surgery
APPLICATIONS
- AMPUTATIONS

Table 1 MAIN CAUSES OF LIMB LOSS OR DEFICIENCY IN THE U.S.
Table 2 PERSONS IN THE U.S., LIVING WITH LIMB LOSS, BY AGE GROUP (NUMBER, %)
Figure 1 PERSONS IN THE U.S., LIVING WITH LIMB LOSS, BY AGE GROUP (%)
Table 3 NEW BREAST CANCER CASES DIAGNOSED IN THE U.S, 1999-2004 (THOUSANDS)
Figure 2 NEW BREAST CANCER CASES DIAGNOSED IN THE U.S, 1999-2004 (THOUSANDS)
Table 4 ORIGIN, LOCATION AND COMMON AGE FOR TYPES OF BONE CANCER
Table 5 HOSPITALIZATIONS, PHYSICIAN OFFICE VISITS AND DEATHS DUE TO HEART DISEASE IN THE U.S., 2001/2002*

PRODUCT TYPES

FUNCTIONAL PROSTHESES
- EXOPROSTHESES
  - Description
  - Applications
  - Technologies
  - Attachment
  - Power Source
    - Body-Powered
    - Electrically Powered
    - Hybrid
  - Control
    - Myoelectric Control
    - Victhom A-Leg
    - Otto Bock C-Leg
    - Activity Specific Prosthesis
  - Terminal Device
    - Prosthetic Hands
    - Prosthetic Feet
  - Articulation
  - Replacement Joint
  - Prosthetic Joints
  - Patents

Table 6 U.S. EXOPROSTHESIS PATENTS ISSUED SINCE 1976 (NUMBER, %)
Figure 3 U.S., EXOPROSTHESIS PATENTS ISSUED SINCE 1976 (%)
Table 7 U.S. EXOPROSTHESIS PATENT HOLDERS, ISSUED SINCE 1976 (NUMBER, %)
Figure 4 U.S., EXOPROSTHESIS PATENT HOLDERS, ISSUED SINCE 1976 (PERCENT OF PATENTS)
Table 8 EXOPROSTHESIS MANUFACTURERS, BY LOCATION AND PRODUCTS
Table 9 U.S. EXOPROSTHETIC MARKET SHARES, 2004 ($ MILLIONS, %)
Figure 5 U.S. EXOPROSTHETIC MARKET SHARES, 2004 (PERCENT OF TOTAL MARKET)
Table 10 CARDIAC PROSTHETIC DEVICES
Table 11 CARDIAC ASSISTANCE/REPLACEMENT DEVICE PATENT HOLDERS, ISSUED SINCE 1976 (NUMBER, %)
Figure 6 CARDIAC ASSISTANCE/REPLACEMENT DEVICE PATENT HOLDERS, ISSUED SINCE 1976 (%)
Table 12 CARDIAC PROSTHESIS MANUFACTURERS
Table 13 U.S., CARDIAC PROSTHESIS MARKET SHARES, 2004 ($ MILLIONS, %)
Figure 7 U.S., CARDIAC PROSTHESIS MARKET SHARES, 2004 (PERCENT OF TOTAL MARKET)
Table 14 COCHLEAR IMPLANT PATENT HOLDERS, SINCE 1976 (NUMBER, %)
Figure 8 COCHLEAR IMPLANT PATENT HOLDERS, SINCE 1976 (%)
Table 15 COCHLEAR IMPLANT PATENTS
Table 16 COCHLEAR IMPLANT MANUFACTURERS
Table 17 COCHLEAR IMPLANT MARKET SHARES, 2004 ($ MILLIONS, %)
Figure 9 COCHLEAR IMPLANT MARKET SHARES, 2004 (PERCENT OF TOTAL MARKET)
Table 18 MIDDLE EAR IMPLANT PATENT HOLDERS, SINCE 1976 (NUMBER, %)
Figure 10 MIDDLE EAR IMPLANT PATENT HOLDERS, SINCE 1976 (%)
Table 19 MIDDLE EAR IMPLANT MANUFACTURERS
Table 20 MIDDLE EAR IMPLANT MARKET SHARES, 2004 ($ MILLIONS, %)
Figure 11 MIDDLE EAR IMPLANT MARKET SHARES, 2004 (PERCENT OF TOTAL SEGMENT SALES) (PERCENT OF TOTAL SALES)
Table 21 URINARY PROSTHETIC SPHINCTER PATENT HOLDERS, ISSUED SINCE 1976 (NUMBER, %)
Figure 12 URINARY PROSTHETIC SPHINCTER PATENT HOLDERS, ISSUED SINCE 1976 (%)
Table 22 URINARY PROSTHESIS MANUFACTURERS
Table 23 U.S. PENILE PROSTHESIS PATENTS ISSUED SINCE 1976, BY TYPE OF PROSTHESIS (NUMBER, %)
Figure 13 U.S. PENILE PROSTHESIS PATENTS ISSUED SINCE 1976, BY TYPE OF PROSTHESIS (PERCENT OF TOTAL PATENTS ISSUED)
Table 24 U.S. PENILE PROSTHESIS PATENT HOLDERS, ISSUED SINCE 1976 (NUMBER, %)
Figure 14 U.S. PENILE PROSTHESIS PATENT HOLDERS, ISSUED SINCE 1976 (%)
Table 25 PENILE IMPLANT MANUFACTURERS U.S. MARKET SHARES, 2004 ($ MILLIONS, %)
Figure 15 PENILE IMPLANT MANUFACTURERS U.S. MARKET SHARES, 2004 (PERCENT OF TOTAL SALES)
Table 26 U.S. DENTAL PROSTHESIS PATENTS ISSUED SINCE 1976 ($ MILLIONS, %)
Figure 16 U.S. DENTAL PROSTHESIS PATENTS ISSUED SINCE 1976 (%)
Table 27 DENTAL PROSTHESIS MANUFACTURERS
Table 28 DENTAL IMPLANT MARKET SHARES, 2004 ($ MILLIONS, %)
Figure 17 DENTAL IMPLANT MARKET SHARES, 2004 (% OF TOTAL SALES)
Table 29 U.S. BONE PROSTHESIS PATENTS, ISSUED SINCE 1976 (NUMBER, %)
Figure 18 U.S. BONE PROSTHESIS PATENTS, ISSUED SINCE 1976 (%)
Table 30 BONE PROSTHESIS MANUFACTURERS
- NON-FUNCTIONAL PROSTHESES
  - EYES
    - Description
    - Applications
    - Technology
      - Ocular Prosthesis
      - Orbital Implants
    - Patents
Table 31 U.S. PATENTS ISSUED SINCE 1976 RELATING TO ARTIFICIAL EYES (NUMBER, %)
Figure 19 U.S. PATENTS ISSUED SINCE 1976 RELATING TO ARTIFICIAL EYES (%)
Table 32 ARTIFICIAL EYE MANUFACTURERS
Table 33 HOLDERS OF U.S. BREAST PROSTHESIS PATENTS, ISSUED SINCE 1976 (NUMBER, %)
Figure 20 HOLDERS OF U.S. BREAST PROSTHESIS PATENTS, ISSUED SINCE 1976 (%)
Table 34 PROSTHETIC BREAST MANUFACTURERS
- ORTHOTICS
  - DESCRIPTION
  - APPLICATIONS
  - TECHNOLOGIES
    - Ankle-Foot Orthoses
    - Foot Orthoses
    - Knee Orthoses
    - Spinal Orthoses
  - PATENTS
Table 35 U.S. ORTHOTICS PATENTS, ISSUED SINCE 1976, BY BODY PART (NUMBER, %)
Figure 21 U.S. ORTHOTICS PATENTS, ISSUED SINCE 1976, BY BODY PART (%)
Table 36 U.S. ORTHOTICS PATENT HOLDERS, ISSUED SINCE 1976 (%)
Table 37 ORTHOTICS MANUFACTURERS
Table 38 LEADING SUPPLIERS TO THE U.S. ORTHOTICS MARKET, 2004 ($ MILLIONS, %)
Figure 22 LEADING SUPPLIERS TO THE U.S. ORTHOTICS MARKET, 2004 (PERCENT OF TOTAL SALES)
- COSMETIC ENHANCEMENT PRODUCTS
  - COSMETIC IMPLANTS
    - Breast Implants
      - Description
      - Applications
      - Technology
      - Patents
      - Manufacturers
    - Facial Implants
      - Description
      - Applications
      - Technology
        
        Solid Silicone
        Porous Polyethylene
        Gore-tex
      - Patents
Table 39 U.S. FACIAL IMPLANT PATENTS, ISSUED SINCE 1976 (NUMBER, %)
Figure 23 U.S. FACIAL IMPLANT PATENTS, ISSUED SINCE 1976 (%)
Table 40 FACIAL IMPLANT MANUFACTURERS
Table 41 DERMAL FILLER MANUFACTURERS

U.S. MARKET FOR PROSTHESES, ORTHOTICS AND COSMETIC ENHANCEMENT PRODUCTS

SUMMARY

Table 42 U.S. MARKET FOR PROSTHETICS ORTHOTICS AND COSMETIC ENHANCEMENT PRODUCTS, THROUGH 2010 ($ MILLIONS)
Figure 24 U.S. MARKET FOR PROSTHETICS ORTHOTICS AND COSMETIC ENHANCEMENT PRODUCTS, 2004-2010 ($ MILLIONS)
Table 43 SHARE OF PROSTHETIC, ORTHOTIC AND COSMETIC ENHANCEMENT PRODUCTS, 2004 AND 2010 (%)
Figure 25 SHARE OF PROSTHETIC, ORTHOTIC AND COSMETIC ENHANCEMENT PRODUCTS, 2004 AND 2010 (%)
- DETAILED MARKET ESTIMATES AND PROJECTIONS, 2004-2010
  - PROSTHETICS
Table 44 U.S. SALES OF FUNCTIONAL AND NON-FUNCTIONAL PROSTHESES, THROUGH 2010 ($ MILLIONS)
Table 45 PROJECTED U.S. MARKET FOR FUNCTIONAL PROSTHESES BY TYPE, THROUGH 2010 ($ MILLIONS)
Table 45 (CONTINUED)
Table 46 SHARE OF U.S. FUNCTIONAL PROSTHESIS MARKET BY TYPE OF DEVICE, 2004 AND 2010 (%)
Figure 26 SHARE OF U.S. FUNCTIONAL PROSTHESIS MARKET BY TYPE OF DEVICE, 2004 AND 2010 (%)
Table 47 SHARE OF U.S. SALES OF EXOPROSTHESES, INCLUDING HIP AND KNEE IMPLANTS (%)
Figure 27 SHARE OF U.S. SALES OF EXOPROSTHESES, INCLUDING HIP AND KNEE IMPANTS (PERCENT OF TOTAL SALES)
Table 48 INCIDENCE OF DIABETES AMONG DIFFERENT AGE GROUPS (%)
Table 49 PROJECTED TRENDS IN U.S. POPULATION 55 YEARS AND OLDER VS. ENTIRE POPULATION (MILLION PERSONS)
Table 50 NUMBER OF U.S. HIP AND KNEE REPLACEMENTS*, THROUGH 2010 (THOUSANDS OF PROCEDURES)
Table 51 PROJECTED U.S. MARKET FOR EXOPROSTHESES, THROUGH 2010 ($ MILLIONS)
Table 52 U.S. HEART TRANSPLANT TRENDS, 1999-2004
Figure 28 U.S. HEART TRANSPLANT TRENDS, 1999-2004 (NUMBER)
Table 53 SOURCES OF MEDICAL INSURANCE COVERAGE FOR AMERICANS 65 YEARS AND OLDER, 2004 (NUMBER, %)
Figure 29 SOURCES OF MEDICAL INSURANCE COVERAGE FOR AMERICANS 65 YEARS AND OLDER, 2004 (%)
Table 54 U.S. CARDIAC PROSTHESIS SALES, THROUGH 2010 ($ MILLIONS)
Table 55 U.S. SALES OF AUDITORY PROSTHESES BY TYPE, THROUGH 2010 ($ MILLIONS)
Table 56 COCHLEAR IMPLANT MARKET PENETRATION, 2004 (NUMBER, %)
Figure 30 COCHLEAR IMPLANT MARKET PENETRATION, 2004 (%)
Table 57 U.S. SALES OF COCHLEAR IMPLANT, THROUGH 2010 ($ MILLIONS)
Table 58 U.S. SALES OF MIDDLE EAR IMPLANTS, THROUGH 2010 ($ MILLIONS)
Table 59 U.S. MARKET FOR SPINAL NERVE STIMULATORS USED FOR SPINAL CORD INJURY, THROUGH 2010 ($ MILLIONS)
Table 60 U.S. MARKET FOR UROLOGICAL PROSTHESES, THROUGH 2010 ($ MILLIONS)
Table 61 TRENDS IN U.S. SALES OF PENILE IMPLANTS, THROUGH 2010 ($ MILLIONS)
Table 62 TRENDS IN U.S. SALES OF URINARY PROSTHESES, THROUGH 2010 ($ MILLIONS)
Table 63 U.S. SALES OF ARTIFICIAL VS NATURAL BONE SUBSTITUTE MATERIALS, 2004 ($ MILLIONS, %)
Figure 31 U.S. SALES OF ARTIFICIAL VS NATURAL BONE SUBSTITUTE MATERIALS, 2004 (PERCENT OF TOTAL SALES)
Table 64 PROJECTED U.S., MARKET FOR BONE GRAFT MATERIALS, THROUGH 2010 ($ MILLIONS)
Table 65 PROJECTED U.S. MARKET FOR ARTIFICIAL BONE GRAFT MATERIALS, THROUGH 2010 ($ MILLIONS)
Table 66 U.S. DENTAL PROSTHETIC MARKET BY TYPE, 2004 ($ MILLIONS, %)
Figure 32 U.S. DENTAL PROSTHETIC MARKET BY TYPE, 2004 (PERCENT OF TOTAL SALES)
Table 67 U.S. MARKET FOR DENTAL PROSTHESES BY TYPE, THROUGH 2010 ($ MILLIONS)
Table 68 U.S. MARKET FOR NON-FUNCTIONAL PROSTHESES BY TYPE, THROUGH 2010 ($ MILLIONS)
Table 69 U.S. MARKET FOR EXTERNAL AND IMPLANTED BREAST PROSTHESES, 2004 ($ MILLIONS, %)
Figure 33 U.S. MARKET FOR EXTERNAL AND IMPLANTED BREAST PROSTHESES, 2004 (PERCENT OF TOTAL SALES)
Table 70 TRENDS IN THE NUMBER OF NEW BREAST CANCER CASES IN THE U.S., THROUGH 2004 (THOUSAND CASES)
Table 71 U.S. MARKET FOR EXTERNAL AND IMPLANTED BREAST PROSTHESES, THROUGH 2010 ($ MILLIONS)
Table 72 U.S. MARKET FOR ARTIFICIAL EYES BY TYPE, 2004 ($ MILLIONS, %)
Figure 34 U.S. MARKET FOR ARTIFICIAL EYES BY TYPE, 2004 (PERCENT OF TOTAL SALES)
Table 73 U.S. SALES OF ARTIFICIAL EYES, THROUGH 2010 ($ MILLIONS)
Table 74 U.S. ORTHOTICS MARKET BY TYPE, 2004 ($ MILLIONS, %)
Figure 35 U.S. ORTHOTICS MARKET BY TYPE, 2004 (PERCENT OF TOTAL SALES)
Table 75 U.S., POPULATION BY AGE GROUP, THROUGH 2010 (MILLION PERSONS)
Table 76 TRENDS IN U.S. POPULATION 55 AND OLDER, 2004 AND 2010 (PERCENT OF TOTAL U.S. POPULATION)
Figure 36 TRENDS IN U.S. POPULATION 55 AND OLDER, 2004 AND 2010 (PERCENT OF TOTAL U.S. POPULATION)
Table 77 TRENDS IN U.S., SPORTS PARTICIPATION, 1999 AND 2004 (MILLIONS OF AMERICANS PARTICIPATING IN SPORTS AT LEAST ONCE)
Figure 37 TRENDS IN U.S., SPORTS PARTICIPATION, 1999 AND 2004 (MILLIONS OF AMERICANS PARTICIPATING IN SPORTS AT LEAST ONCE)
Table 78 U.S. SALES OF ORTHOTIC DEVICES, THROUGH 2010 ($ MILLIONS)
Table 79 U.S. SALES OF COSMETIC ENHANCEMENT PRODUCTS BY TYPE, THROUGH 2004 ($ MILLIONS)
Table 80 TRENDS IN U.S. COSMETIC BREAST IMPLANT PROCEDURES, 1999-2004
Table 81 U.S. SALES OF COSMETIC BREAST IMPLANTS, THROUGH 2010 ($ MILLIONS)
Table 82 MAJOR FACIAL COSMETIC PROCEDURES, THROUGH 2004
Table 83 U.S. SALES OF FACIAL IMPLANTS, THROUGH 2010 ($ MILLIONS)
Table 84 U.S. MARKET FOR BOTULINUM INJECTIONS, THROUGH 2010 ($ MILLIONS)
Table 85 U.S. DERMAL FILLER SALES BY TYPE, 2004 ($ MILLIONS, %)
Figure 38 U.S. DERMAL FILLER SALES BY TYPE, 2004 (PERCENT OF TOTAL SALES)
Table 87 U.S. MARKET FOR DERMAL IMPLANTS*, THROUGH 2010 ($ MILLIONS)

VENDOR PROFILES

ABIOMED, INC.

Table 88 ABIOMED FINANCIAL PERFORMANCE 2001-2004 ($ MILLIONS)
- ADVANCED BIONICS CORP.
- ALLERGAN, INC.
- ALLHEAR, INC.
- AMERICAN MEDICAL SYSTEMS
- AMERICAN BREAST CARE
- AMOENA
- ANGSTROM MEDICA. INC.
- ARROW INTERNATIONAL
- BIOMET, INC.
- BLEDSOE BRACE SYSTEMS
- BRAINLAB AG
- B. BRAUN AESCULAP
- CLEVELAND FES CENTER
- COCHLEAR LIMITED
- THE DOBELLE INSTITUTE
- THE FILLAUER COMPANIES
- FINETECH MEDICAL, LTD.
- IMPLANT INNOVATIONS INC.
- INTEGRATED SURGICAL SYSTEMS, INC.
- LIBERATING TECHNOLOGIES, INC.
- MED-EL
- MEDTRONIC INC.
- MENTOR CORP.
- MICROMED TECHNOLOGY INC.
- NEOPRAXIS PTY. LTD.
- NEUROCONTROL INC.
- NOBEL BIOCARE
- ORTHOVITA INC.
- Table 89 ORTHOVITA INC. FINANCIAL PERFORMANCE 1998-2002 ($ MILLIONS)
- OSSUR
- OTOLOGICS, LLC
- OTTO BOCK HEALTHCARE GMBH
- POREX CORPORATION
- SEATTLE SYSTEMS INC.
- SOUNDTEC, INC.
- STRAUMANN HOLDING AG
- STRYKER CORP.
- SYMPHONIX DEVICES
- THORATEC CORP.
  - THORATEC CORP. (CONTINUED)
Table 90 THORATEC CORP. FINANCIAL PERFORMANCE, 2001-2004 ($ MILLIONS)
- VICTHOM HUMAN BIONICS
- WORLDHEART CORP.
Table 91 WORLDHEART CORP. FINANCIAL PERFORMANCE, 2001-2004 ($ MILLIONS)
- ZIMMER INC.

LIST OF TABLES

Summary Table: U.S. MARKET FOR PROSTHETICS, ORTHOTICS AND COSMETIC ENHANCEMENT PRODUCTS, THROUGH 2010 ($ MILLIONS)
Table 1 MAIN CAUSES OF LIMB LOSS OR DEFICIENCY IN THE U.S.
Table 2 PERSONS IN THE U.S., LIVING WITH LIMB LOSS, BY AGE GROUP (NUMBER, %)
Table 3 NEW BREAST CANCER CASES DIAGNOSED IN THE U.S, 1999-2004 (THOUSANDS)
Table 4 ORIGIN, LOCATION AND COMMON AGE FOR TYPES OF BONE CANCER
Table 5 HOSPITALIZATIONS, PHYSICIAN OFFICE VISITS AND DEATHS DUE TO HEART DISEASE IN THE U.S., 2001/2002*
Table 6 U.S. EXOPROSTHESIS PATENTS ISSUED SINCE 1976 (NUMBER, %)
Table 7 U.S. EXOPROSTHESIS PATENT HOLDERS, ISSUED SINCE 1976 (NUMBER, %)
Table 8 EXOPROSTHESIS MANUFACTURERS, BY LOCATION AND PRODUCTS
Table 9 U.S. EXOPROSTHETIC MARKET SHARES, 2004 ($ MILLIONS, %)
Table 10 CARDIAC PROSTHETIC DEVICES
Table 11 CARDIAC ASSISTANCE/REPLACEMENT DEVICE PATENT HOLDERS, ISSUED SINCE 1976 (NUMBER, %)
Table 12 CARDIAC PROSTHESIS MANUFACTURERS
Table 13 U.S., CARDIAC PROSTHESIS MARKET SHARES, 2004 ($ MILLIONS, %)
Table 14 COCHLEAR IMPLANT PATENT HOLDERS, SINCE 1976 (NUMBER, %)
Table 15 COCHLEAR IMPLANT PATENTS
Table 16 COCHLEAR IMPLANT MANUFACTURERS
Table 17 COCHLEAR IMPLANT MARKET SHARES, 2004 ($ MILLIONS, %)
Table 18 MIDDLE EAR IMPLANT PATENT HOLDERS, SINCE 1976 (NUMBER, %)
Table 19 MIDDLE EAR IMPLANT MANUFACTURERS
Table 20 MIDDLE EAR IMPLANT MARKET SHARES, 2004 ($ MILLIONS, %)
Table 21 URINARY PROSTHETIC SPHINCTER PATENT HOLDERS, ISSUED SINCE 1976 (NUMBER, %)
Table 22 URINARY PROSTHESIS MANUFACTURERS
Table 23 U.S. PENILE PROSTHESIS PATENTS ISSUED SINCE 1976, BY TYPE OF PROSTHESIS (NUMBER, %)
Table 24 U.S. PENILE PROSTHESIS PATENT HOLDERS, ISSUED SINCE 1976 (NUMBER, %)
Table 25 PENILE IMPLANT MANUFACTURERS U.S. MARKET SHARES, 2004 ($ MILLIONS, %)
Table 26 U.S. DENTAL PROSTHESIS PATENTS ISSUED SINCE 1976 ($ MILLIONS, %)
Table 27 DENTAL PROSTHESIS MANUFACTURERS
Table 28 DENTAL IMPLANT MARKET SHARES, 2004 ($ MILLIONS, %)
Table 29 U.S. BONE PROSTHESIS PATENTS, ISSUED SINCE 1976 (NUMBER, %)
Table 30 BONE PROSTHESIS MANUFACTURERS
Table 31 U.S. PATENTS ISSUED SINCE 1976 RELATING TO ARTIFICIAL EYES (NUMBER, %)
Table 32 ARTIFICIAL EYE MANUFACTURERS
Table 33 HOLDERS OF U.S. BREAST PROSTHESIS PATENTS, ISSUED SINCE 1976 (NUMBER, %)
Table 34 PROSTHETIC BREAST MANUFACTURERS
Table 35 U.S. ORTHOTICS PATENTS, ISSUED SINCE 1976, BY BODY PART (NUMBER, %)
Table 36 U.S. ORTHOTICS PATENT HOLDERS, ISSUED SINCE 1976 (%)
Table 37 ORTHOTICS MANUFACTURERS
Table 38 LEADING SUPPLIERS TO THE U.S. ORTHOTICS MARKET, 2004 ($ MILLIONS, %)
Table 39 U.S. FACIAL IMPLANT PATENTS, ISSUED SINCE 1976 (NUMBER, %)
Table 40 FACIAL IMPLANT MANUFACTURERS
Table 41 DERMAL FILLER MANUFACTURERS
Table 42 U.S. MARKET FOR PROSTHETICS ORTHOTICS AND COSMETIC ENHANCEMENT PRODUCTS, THROUGH 2010 ($ MILLIONS)
Table 43 SHARE OF PROSTHETIC, ORTHOTIC AND COSMETIC ENHANCEMENT PRODUCTS, 2004 AND 2010 (%)
Table 44 U.S. SALES OF FUNCTIONAL AND NON-FUNCTIONAL PROSTHESES, THROUGH 2010 ($ MILLIONS)
Table 45 PROJECTED U.S. MARKET FOR FUNCTIONAL PROSTHESES BY TYPE, THROUGH 2010 ($ MILLIONS)
Table 46 SHARE OF U.S. FUNCTIONAL PROSTHESIS MARKET BY TYPE OF DEVICE, 2004 AND 2010 (%)
Table 47 SHARE OF U.S. SALES OF EXOPROSTHESES, INCLUDING HIP AND KNEE IMPLANTS (%)
Table 48 INCIDENCE OF DIABETES AMONG DIFFERENT AGE GROUPS (%)
Table 49 PROJECTED TRENDS IN U.S. POPULATION 55 YEARS AND OLDER VS. ENTIRE POPULATION (MILLION PERSONS)
Table 50 NUMBER OF U.S. HIP AND KNEE REPLACEMENTS*, THROUGH 2010 (THOUSANDS OF PROCEDURES)
Table 51 PROJECTED U.S. MARKET FOR EXOPROSTHESES, THROUGH 2010 ($ MILLIONS)
Table 52 U.S. HEART TRANSPLANT TRENDS, 1999-2004
Table 53 SOURCES OF MEDICAL INSURANCE COVERAGE FOR AMERICANS 65 YEARS AND OLDER, 2004 (NUMBER, %)
Table 54 U.S. CARDIAC PROSTHESIS SALES, THROUGH 2010 ($ MILLIONS)
Table 55 U.S. SALES OF AUDITORY PROSTHESES BY TYPE, THROUGH 2010 ($ MILLIONS)
Table 56 COCHLEAR IMPLANT MARKET PENETRATION, 2004 (NUMBER, %)
Table 57 U.S. SALES OF COCHLEAR IMPLANT, THROUGH 2010 ($ MILLIONS)
Table 58 U.S. SALES OF MIDDLE EAR IMPLANTS, THROUGH 2010 ($ MILLIONS)
Table 59 U.S. MARKET FOR SPINAL NERVE STIMULATORS USED FOR SPINAL CORD INJURY, THROUGH 2010 ($ MILLIONS)
Table 60 U.S. MARKET FOR UROLOGICAL PROSTHESES, THROUGH 2010 ($ MILLIONS)
Table 61 TRENDS IN U.S. SALES OF PENILE IMPLANTS, THROUGH 2010 ($ MILLIONS)
Table 62 TRENDS IN U.S. SALES OF URINARY PROSTHESES, THROUGH 2010 ($ MILLIONS)
Table 63 U.S. SALES OF ARTIFICIAL VS NATURAL BONE SUBSTITUTE MATERIALS, 2004 ($ MILLIONS, %)
Table 64 PROJECTED U.S., MARKET FOR BONE GRAFT MATERIALS, THROUGH 2010 ($ MILLIONS)
Table 65 PROJECTED U.S. MARKET FOR ARTIFICIAL BONE GRAFT MATERIALS, THROUGH 2010 ($ MILLIONS)
Table 66 U.S. DENTAL PROSTHETIC MARKET BY TYPE, 2004 ($ MILLIONS, %)
Table 67 U.S. MARKET FOR DENTAL PROSTHESES BY TYPE, THROUGH 2010 ($ MILLIONS)
Table 68 U.S. MARKET FOR NON-FUNCTIONAL PROSTHESES BY TYPE, THROUGH 2010 ($ MILLIONS)
Table 69 U.S. MARKET FOR EXTERNAL AND IMPLANTED BREAST PROSTHESES, 2004 ($ MILLIONS, %)
Table 70 TRENDS IN THE NUMBER OF NEW BREAST CANCER CASES IN THE U.S., THROUGH 2004 (THOUSAND CASES)
Table 71 U.S. MARKET FOR EXTERNAL AND IMPLANTED BREAST PROSTHESES, THROUGH 2010 ($ MILLIONS)
Table 72 U.S. MARKET FOR ARTIFICIAL EYES BY TYPE, 2004($ MILLIONS, %)
Table 73 U.S. SALES OF ARTIFICIAL EYES, THROUGH 2010 ($ MILLIONS)
Table 74 U.S. ORTHOTICS MARKET BY TYPE, 2004 ($ MILLIONS, %)
Table 75 U.S., POPULATION BY AGE GROUP, THROUGH 2010 (MILLION PERSONS)
Table 76 TRENDS IN U.S. POPULATION 55 AND OLDER, 2004 AND 2010 (PERCENT OF TOTAL U.S. POPULATION)
Table 77 TRENDS IN U.S., SPORTS PARTICIPATION, 1999 AND 2004 (MILLIONS OF AMERICANS PARTICIPATING IN SPORTS AT LEAST ONCE)
Table 78 U.S. SALES OF ORTHOTIC DEVICES, THROUGH 2010 ($ MILLIONS)
Table 79 U.S. SALES OF COSMETIC ENHANCEMENT PRODUCTS BY TYPE, THROUGH 2004 ($ MILLIONS)
Table 80 TRENDS IN U.S. COSMETIC BREAST IMPLANT PROCEDURES, 1999-2004
Table 81 U.S. SALES OF COSMETIC BREAST IMPLANTS, THROUGH 2010 ($ MILLIONS)
Table 82 MAJOR FACIAL COSMETIC PROCEDURES, THROUGH 2004
Table 83 U.S. SALES OF FACIAL IMPLANTS, THROUGH 2010 ($ MILLIONS)
Table 84 U.S. MARKET FOR BOTULINUM INJECTIONS, THROUGH 2010 ($ MILLIONS)
Table 85 U.S. DERMAL FILLER SALES BY TYPE, 2004 ($ MILLIONS, %)
Table 87 U.S. MARKET FOR DERMAL IMPLANTS*, THROUGH 2010 ($ MILLIONS)
Table 88 ABIOMED FINANCIAL PERFORMANCE 2001-2004 ($ MILLIONS)
Table 89 ORTHOVITA INC. FINANCIAL PERFORMANCE 1998-2002 ($ MILLIONS)
Table 90 THORATEC CORP. FINANCIAL PERFORMANCE, 2001-2004 ($ MILLIONS)
Table 91 WORLDHEART CORP. FINANCIAL PERFORMANCE, 2001-2004 ($ MILLIONS)

LIST OF FIGURES

Summary Figure: U.S. MARKET FOR PROSTHETICS, ORTHOTICS AND COSMETIC ENHANCEMENT PRODUCTS, 2004-2010
Figure 1 PERSONS IN THE U.S., LIVING WITH LIMB LOSS, BY AGE GROUP (%)
Figure 2 NEW BREAST CANCER CASES DIAGNOSED IN THE U.S, 1999-2004 (THOUSANDS)
Figure 3 U.S., EXOPROSTHESIS PATENTS ISSUED SINCE 1976 (%)
Figure 4 U.S., EXOPROSTHESIS PATENT HOLDERS, ISSUED SINCE 1976 (PERCENT OF PATENTS)
Figure 5 U.S. EXOPROSTHETIC MARKET SHARES, 2004 (PERCENT OF TOTAL MARKET)
Figure 6 CARDIAC ASSISTANCE/REPLACEMENT DEVICE PATENT HOLDERS, ISSUED SINCE 1976 (%)
Figure 7 U.S., CARDIAC PROSTHESIS MARKET SHARES, 2004 (PERCENT OF TOTAL MARKET)
Figure 8 COCHLEAR IMPLANT PATENT HOLDERS, SINCE 1976 (%)
Figure 9 COCHLEAR IMPLANT MARKET SHARES, 2004 (PERCENT OF TOTAL MARKET)
Figure 10 MIDDLE EAR IMPLANT PATENT HOLDERS, SINCE 1976 (%)
Figure 11 MIDDLE EAR IMPLANT MARKET SHARES, 2004 (PERCENT OF TOTAL SEGMENT SALES) (PERCENT OF TOTAL SALES)
Figure 12 URINARY PROSTHETIC SPHINCTER PATENT HOLDERS, ISSUED SINCE 1976 (%)
Figure 13 U.S. PENILE PROSTHESIS PATENTS ISSUED SINCE 1976, BY TYPE OF PROSTHESIS (PERCENT OF TOTAL PATENTS ISSUED)
Figure 14 U.S. PENILE PROSTHESIS PATENT HOLDERS, ISSUED SINCE 1976 (%)
Figure 15 PENILE IMPLANT MANUFACTURERS U.S. MARKET SHARES, 2004 (PERCENT OF TOTAL SALES)
Figure 16 U.S. DENTAL PROSTHESIS PATENTS ISSUED SINCE 1976 (%)
Figure 17 DENTAL IMPLANT MARKET SHARES, 2004 (% OF TOTAL SALES)
Figure 18 U.S. BONE PROSTHESIS PATENTS, ISSUED SINCE 1976 (%)
Figure 19 U.S. PATENTS ISSUED SINCE 1976 RELATING TO ARTIFICIAL EYES (%)
Figure 20 HOLDERS OF U.S. BREAST PROSTHESIS PATENTS, ISSUED SINCE 1976 (%)
Figure 21 U.S. ORTHOTICS PATENTS, ISSUED SINCE 1976, BY BODY PART (%)
Figure 22 LEADING SUPPLIERS TO THE U.S. ORTHOTICS MARKET, 2004 (PERCENT OF TOTAL SALES)
Figure 23 U.S. FACIAL IMPLANT PATENTS, ISSUED SINCE 1976 (%)
Figure 24 U.S. MARKET FOR PROSTHETICS ORTHOTICS AND COSMETIC ENHANCEMENT PRODUCTS, 2004-2010 ($ MILLIONS)
Figure 25 SHARE OF PROSTHETIC, ORTHOTIC AND COSMETIC ENHANCEMENT PRODUCTS, 2004 AND 2010 (%)
Figure 26 SHARE OF U.S. FUNCTIONAL PROSTHESIS MARKET BY TYPE OF DEVICE, 2004 AND 2010 (%)
Figure 27 SHARE OF U.S. SALES OF EXOPROSTHESES, INCLUDING HIP AND KNEE IMPANTS (PERCENT OF TOTAL SALES)
Figure 28 U.S. HEART TRANSPLANT TRENDS, 1999-2004 (NUMBER)
Figure 29 SOURCES OF MEDICAL INSURANCE COVERAGE FOR AMERICANS 65 YEARS AND OLDER, 2004 (%)
Figure 30 COCHLEAR IMPLANT MARKET PENETRATION, 2004 (%)
Figure 31 U.S. SALES OF ARTIFICIAL VS NATURAL BONE SUBSTITUTE MATERIALS, 2004 (PERCENT OF TOTAL SALES)
Figure 32 U.S. DENTAL PROSTHETIC MARKET BY TYPE, 2004 (PERCENT OF TOTAL SALES)
Figure 33 U.S. MARKET FOR EXTERNAL AND IMPLANTED BREAST PROSTHESES, 2004 (PERCENT OF TOTAL SALES)
Figure 34 U.S. MARKET FOR ARTIFICIAL EYES BY TYPE, 2004 (PERCENT OF TOTAL SALES)
Figure 35 U.S. ORTHOTICS MARKET BY TYPE, 2004 (PERCENT OF TOTAL SALES)
Figure 36 TRENDS IN U.S. POPULATION 55 AND OLDER, 2004 AND 2010 (PERCENT OF TOTAL U.S. POPULATION)
Figure 37 TRENDS IN U.S., SPORTS PARTICIPATION, 1999 AND 2004 (MILLIONS OF AMERICANS PARTICIPATING IN SPORTS AT LEAST ONCE)
Figure 38 U.S. DERMAL FILLER SALES BY TYPE, 2004 (PERCENT OF TOTAL SALES)